An 85-year-old woman with chronic renal insufficiency presented with appetite loss and abdominal fullness. Laboratory data showed serum creatinine levels of 5.46 mg/ dL, urea nitrogen 42 mg/dL, corrected calcium 15.3 mg/ dL, intact PTH -parathyroid hormone 15.1 pg/mL (N 10-65), calcitriol 63.4 pg/mL (N 20-60), PTH-related protein 5.5 pmol/L (N < 1.0), cortisol of 4.3 pg/mL (N 6.2-19.4), ACTH -adrenocorticotropic hormone 304 pg/mL (N 7.2-63.3) and soluble interleukin-2 receptor of 2335 U/mL (N 206-713). These results signify that the patient suffered from exacerbation of chronic renal failure, adrenal insufficiency and severe hypercalcemia probably caused by excessive calcitriol and PTH-related protein. Magnetic resonance imaging and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography imaging disclosed giant masses bilaterally in the adrenal glands ( Figure 1A and B); the masses were histologically diagnosed as extranodal malignant B-cell lymphoma (Figure 2A ), which was also positive for 25-hydroxyvitamin D 3 -1-alpha-hydroxylase ( Figure  2B ), suggesting extra-renal overproduction of calcitriol. Hypercalcemia was normalized (8.9 mg/dL) shortly after hydrocortisone and zoledronate treatment concomitant with serum calcitriol decline (20.6 pg/mL) and serum cortisol increase (16.3 pg/mL), although PTH-related protein remained high (5.5 pmol/L). Additionally, serum FGF23 -fibroblast growth factor 23 (FGF23) level decreased from 9050 to 258 pg/mL (N 10-50). The patient died 2 months after hospitalization due to lymphoma progression.
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Hypercalcemia is occasionally seen in malignant lymphoma [1] . Common causes of lymphoma-related hypercalcemia include overproduction of calcitriol and PTH-related protein and local osteolysis induced by inflammatory cytokines [2] . In the present case, hypercalcemia was caused by excessive calcitriol and PTH-related protein. Besides, adrenal insufficiency, which was normalized after hydrocortisone treatment, might also contribute to the development of hypercalcemia [3] . In addition, high serum FGF23 level decreased in parallel with the decline in serum calcitriol, indicating that endogeneous calcitriol overproduction stimulated the production of FGF23 in the bone.
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